Cutting Edge At-Home MedTech and Digital Health Companies, Satio and Nanowear, to Collaborate on Accelerating Non-invasive Biomarkers, Diagnostics and Drug Delivery, Beyond the Remote Monitoring and Digital Assessment Tools Used Today
BOSTON and NEW YORK, April 14, 2025 /PRNewswire/ — Satio and Nanowear have agreed to partner to advance patient-friendly, home-based diagnostic, and therapeutic care. This collaboration integrates Nanowear’s at-home AI-based nanotechnology biomarker diagnostic platform with Satio’s at-home blood draw diagnostics and drug delivery systems/patches: combining time synchronous, in vivo and in vitro diagnostics for precision therapeutics and individualized AI-based […]
Satio Successfully Completes Development and Testing of Novel At-Home, Remotely Controllable, Intradermal Drug Delivery System, Achieving the First Fully Executed ARPA-H Small Business Contract
BOSTON, April 7, 2025 /PRNewswire/ — Satio, Inc. is pleased to announce the successful completion of a Small Business Innovation Research contract awarded by the Advanced Research Projects Agency for Health (ARPA-H). The company’s ground-breaking SatioRx drug delivery device has been designed to provide stable and controlled delivery of liquid medicines through a hollow microneedle (HMN) […]
Small business research team develops low-cost reusable intradermal drug delivery device | ARPA-H
The Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services (HHS), today announced a commercially viable intradermal microneedle drug delivery device designed for home use. The project that developed this device is part of ARPA-H’s Small Business Innovation Research (SBIR) initiative to propel high-impact biomedical research […]